Basic Information
Vedere Bio, composed of a diverse team of pioneering scientists, is discovering and developing next-generation ocular gene therapy products to restore functional vision in patients blinded by inherited retinal degenerations (IRDs), as well as other genetic and non-genetic causes of vision loss. With their ocular gene therapy toolkit, they focus on high-quality vision restoration and preservation to bring life-changing technologies to patients worldwide.
Vedere Bio II, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2019
info@vederebio.com

